Wound Management 2007-2016

Worldwide Wound Management, 2007-2016:
Established and Emerging Products, Technologies and Markets
in the U.S., Europe, Japan and Rest of World

· 256 pages · 64 Exhibits · 69 Company Profiles · Report #S245 · Published Nov. 2007

This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report details current clinical and technology developments in this huge worldwide market with high growth sectors, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying the huge and evolving worldwide wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced wound care research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Table of Contents

EXECUTIVE SUMMARY

Acute Wounds

Burns

Chronic Wounds

Products Used in Advanced Wound Management

Film Dressings

Hydrocolloid Dressings

Foam dressings

Alginate Dressings

Hydrogels

Non-Adherent Dressings

Anti-Microbial Dressings

Wound Cleansers and Debriding Agents

Skin Replacements and Substitutes

Pharmacological Products

Physical Therapies

The Market

The Industry

Section 1: BACKGROUND

1.1       Industry Structure

1.2       A Complex Industry

1.3       Major Wound Management Corporations

1.4       Historical Perspective and Technology Breakthroughs

1.5       World-Wide Regulatory and Reimbursement Environment

1.5.1          Cost Effectiveness

1.5.2          Clinical

1.5.3          Regulatory

1.5.4          Reimbursement

1.5.4.1       U.S.A.

1.5.4.2       European Union

1.5.4.3       France

1.5.4.4       Germany

1.5.4.5       United Kingdom

1.5.4.6       Italy

1.5.4.7       Belgium

1.5.4.8       Spain

1.5.4.9       Scandinavia

1.6       Geographical Differences in Treatments of Wounds

1.7       Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence

1.8       Wound Management Trends

1.8.1          Surgical Wounds

1.8.2          Traumatic Wounds

1.8.3          Burns

1.8.4          Chronic Wounds

1.9       Market Dynamics

Section 2: CLINICAL BACKGROUND AND CASELOAD

2.1       Background

2.1.1          A few Figures

2.1.2          Overview of Functions

2.1.3          Skin Anatomy: A Summary

2.2       Types of Wounds

2.2.1          Classification By Severity

2.2.2          Classification By Morphology

2.2.3          Classification By Etiology

2.2.4          Color Classification

2.3       Surgical Wounds

2.4       Traumatic Wounds

2.5       Burns

2.5.1          Debridement

2.5.2          Grafting

2.6       Pressure Ulcers

2.6.1          Ulcer Classification

2.6.2          Hospital-Acquired Ulcers

2.6.3          Management of Pressure Ulcers

2.7       Venous Ulcers

2.8       Arterial Ulcers

2.9       Diabetic Ulcers

2.9.1          Prevalence

2.9.2          Stages of Diabetic Ulcer

2.9.3          Treatment

2.9.3.1       Amputations

2.9.3.2       Abnormal Scarring

2.9.4          Acquired Immunodeficiency Syndrome

2.10     Wound Healing Physiology

2.10.1        Inflammatory Phase

2.10.2        Proliferative Phase

2.10.2.1     Angiogenesis

2.10.3        Maturation Phase

2.11     Factors Affecting Wound Healing

2.11.1        Extrinsic Factors

2.11.2        Mechanical Stress

2.11.3        Debris

2.11.4        Temperature

2.11.5        Desiccation and Maceration

2.11.6        Infection

2.11.7        Chemical Stress

2.11.8        Medication

2.11.9        Other Extrinsic Factors

2.11.10      Intrinsic Factors

2.11.11      Health Status

2.11.12      Age Factors

2.11.13      Body Build

2.11.14      Nutritional Status

2.12     Major Treatment Categories and Regimes

2.13     Incidence of Treatments, Growth Rates and Trends

Section 3: PRODUCTS, TECHNOLOGIES AND MARKETS

3.1       Background

3.2       Film Dressings

3.2.1          Overview

3.2.2          Product Examples

3.2.3          Market and Competitive Activity

3.3       Hydrocolloids

3.3.1          Overview

3.3.2          Product Examples

3.3.3          Market and Competitive Activity

3.4       Foam Dressings

3.4.1          Overview

3.4.2          Product Examples

3.4.3          Market and Competitive Activity

3.5       Alginate Dressings

3.5.1          Overview

3.5.2          Product Examples

3.5.3          Market and Competitive Activity

3.6       Hydrogels

3.6.1          Overview

3.6.2          Product Examples

3.6.3          Market and Competitive Activity

3.7       Non Adherent Dressings

3.7.1          Overview

3.7.2          Product Examples

3.7.3          Market and Competitive Activity

3.8       Antimicrobial Dressings

3.8.1          Overview

3.8.2          Product Examples

3.8.3          Market and Competitive Activity

3.9       Tissue Engineered Products

3.9.1          Overview

3.9.2          Traditional skin grafts

3.9.3          Skin replacements

3.9.4          Product Examples

3.9.5          Market and Competitive Analysis

3.10     Pharmacological Products

3.10.1        Overview

3.10.2        Product Examples

3.10.2.1     Growth Factors

3.10.2.2     Growth factors: background

3.10.2.3     Classification

3.10.2.4     Regranex

3.10.2.5     Other Growth Factors

3.10.2.6     Non-Growth Factor Modulators

3.10.3        Market and Competitive Analysis

3.10.3.1     Growth Factors

3.10.3.2     Non-Growth Factor Stimulants

3.10.3.3     Gene Therapy

3.11     Physical Treatments

3.11.1        Negative Pressure Devices

3.11.2        Positive Pressure Devices

3.11.3        Mechanically-assisted Wound Closure

3.11.4        Other Physical Wound Therapies

3.11.4.1     Hydrotherapy

3.11.4.2     Electrical Stimulation

3.11.4.3     Electromagnetic Stimulation Devices

3.11.4.4     Ultraviolet Therapy

3.11.4.5     Hyperbaric Oxygen Therapy

3.11.4.6     Ultrasound Devices

3.11.4.7     Laser Devices

3.11.4.8     Wound Imaging/Documentation

3.11.5        Market and Competitive Analysis

3.11.5.1     Pressure Relief Devices

3.11.5.2     Hydrotherapy

3.11.5.3     Electrical Stimulation

3.11.5.4     Hyperbaric Oxygen Therapy

Section 4: Country Market Analysis

4.1       Global Overview

4.2       Market Estimates

4.2.1          Market Potential

4.2.2          Leading Wound Care Companies

4.2.3          Leading National Markets

4.3       USA

4.3.1          Market Opportunity

4.3.2          Market for Advanced Wound Management Products

4.4       Japan

4.4.1          Wound Care Market

4.4.2          Market Opportunity

4.4.3          Leading Companies

4.5       Germany

4.5.1          Wound Care Market

4.5.2          Leading Companies

4.6       France

4.6.1          Wound Care Market

4.6.2          Leading Companies

4.7       Italy

4.7.1          Wound Care Market

4.7.2          Leading Companies

4.8       United Kingdom

4.8.1          Wound Care Market

4.8.2          Leading Companies

Section 5: COMPANY PROFILES

5.1       Major Companies

5.1.1          Carrington Laboratories Inc.

5.1.2          Coloplast Group

5.1.2.1       Financials

5.1.3          ConvaTec Inc.

5.1.4          Covidien

5.1.4.1       Kendall

5.1.4.2       Financial data

5.1.5          Derma Sciences Inc.

5.1.5.1       Financials

5.1.6          DeRoyal Industries Inc.

5.1.7          Ethicon (Johnson & Johnson)

5.1.8          Gentell Inc.

5.1.9          Geritrex Corp.

5.1.10        Hartmann Group

5.1.11        Hollister Incorporated

5.1.12        Lohmann and Rauscher International GmbH and Co. KG

5.1.13        Medline Industries

5.1.13.1     Advanced Wound Care Products

5.1.14        3M Group

5.1.14.1     Financial data

5.1.15        Mölnlycke Health Care AB

5.1.16        Smith and Nephew Group

5.1.16.1     Financial data

5.1.17        UDL Laboratories (Mylan Labs.)

5.2       Specialist Companies

5.2.1          Antimicrobial Dressings

5.2.1.1       Acrymed Inc.

5.2.1.2       Argentum Products LLC

5.2.1.3       Microban International Ltd

5.2.2          Oxygen Therapy

5.2.2.1       Perry Baromedical Corp.

5.2.3          Tissue Regeneration

5.2.3.1       Advanced BioHealing

5.2.3.2       BioTissue Technologies AG

5.2.3.3       Celltran Limited

5.2.3.4       Fidia Group

5.2.3.5       Genzyme Biosurgery

5.2.3.6       Innogenetics

5.2.3.7       Integra Life Sciences Inc.

5.2.3.8       IsoTis S.A

5.2.3.9       Modex Therapeutics

5.2.3.10     Organogenesis Inc.

5.2.3.11     Ortec International Inc.

5.2.4          Negative Pressure Wound Therapy

5.2.4.1       Kinetic Concepts Inc.

5.2.4.2       BlueSky Medical Group (Smith & Nephew)

5.2.5          Growth Factors

5.2.5.1       E.S. Cell International

5.2.6          Electrical Therapies

5.2.6.1       BioMedical Life Systems Inc

5.2.6.2       Diapulse Corp of America

5.2.6.3       Electromedical Products International Inc.

5.2.6.4       Globalcare Medical

5.2.6.5       Microvas Technologies

5.2.7          Odor Control

5.2.7.1       CliniMed

5.2.8          Other Therapeutic Modalities

5.2.8.1       AGT Sciences Ltd

5.2.8.2       Agennix

5.2.8.3       Advanced Medical Solutions Group plc

5.2.8.4       Anodyne Therapy LLC

5.2.8.5       Applied Tissue Technologies

5.2.8.6       Roho Inc.

5.2.9          Summary Profiles

5.2.9.1       AciesHealth

5.2.9.2       Bard Medical Division

5.2.9.3       Biocore Medical Technologies Inc.

5.2.9.4       Biomarin Pharmaceuticals Inc.

5.2.9.5       Brennen Medical Inc.

5.2.9.6       Dermacor Inc.

5.2.9.7       Derma Rite Industries LLC

5.2.9.8       Encelle Inc.

5.2.9.9       Ferris Manufacturing Corp.

5.2.9.10     Fibrogen

5.2.9.11     Geistlich Pharma

5.2.9.12     HemCon Inc

5.2.9.13     Hymed Group Corporation

5.2.9.14     Innocol, Inc.

5.2.9.15     Integra Life Sciences Holdings Corp.

5.2.9.16     Laboratoires Urgo

5.2.9.17     L.A.M. Pharmaceutical Corp.

5.2.9.18     Lifewave Ltd

5.2.9.19     Longport Inc.

5.2.9.20     Nagor Ltd.

5.2.9.21     SSL International Plc

5.2.9.22     Swiss American Products, Inc.

5.2.9.22.1        Wound Care Products

appendix: LIST OF COMPANIES

List of Exhibits

Exhibit ES-1: Advanced Wound Care Market, by Segment, 2007 & 2016

Exihbit ES-2: Advanced Wound Care Market Shares by Competitor, 2007

Exhibit 1-1: Worldwide Wound Incidence by Etiology, 2007

Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2007-2016

Exhibit 1-3: Total World Wound Management Products, Market Forecast, 2005-2014

Exhibit 2-1: Classification of Wounds by Etiology

Exhibit 2-2: Old and New Classification Systems for Burns

Exhibit 2-3: Distribution of Pressure Ulcers

Exhibit 3-1: Companies and Products in the Film Dressings Category

Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2007-2016

Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2007

Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category

Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2007-2016

Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2007

Exhibit 3-7: Companies and Products in the Foam Dressings Category

Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2007-2016

Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2007

Exhibit 3-10: Companies and Products in the Alginate Dressings Category

Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2007-2016

Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2007

Exhibit 3-13: Amorphous Hydrogels - Companies and Products

Exhibit 3-14: Impregnated Hydrogels – Companies and Products

Exhibit 3-15: Sheet Hydrogels -Companies and Products

Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2007- 2016

Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2007

Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category

Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2007-2016

Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2007

Exhibit 3-21: Companies and Products in the Dressings Category

Exhibit 3-22: Antimicrobial Dressings, Worldwide Market Forecast, 2007-2016

Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2007

Exhibit 3-24: Companies and Products in the Tissue Engineering Category

Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2007-2016

Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2007

Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2007-2016

Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category

Exhibit 3-29: Physical Wound Therapies, Worldwide Market Forecast, 2007-2016

Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2007-2016

Exhibit 4-2: Leading Global Wound Care Companies

Exhibit 4-3: Leading Global Wound Care Companies, Market Share 2007

Exhibit 4-4: National Shares of the Global Advanced Wound Management Market, 2007

Exhibit 4-5: Forecast U.S. Sales for Advanced Wound Management Products for the Period 2007-2016

Exhibit 4-6: Forecast U.S. Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016

Exhibit 4-7: Japanese Sales for Advanced Wound Management Products for the Period 2007-2016

Exhibit 4-8: Japanese Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016

Exhibit 4-9: German Sales for Advanced Wound Management Products for the Period 2007-2016

Exhibit 4-10: German Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016

Exhibit 4-11: French Sales for Advanced Wound Management Products for the period 2007-2016

Exhibit 4-12: French Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016: $ millions

Exhibit 4-13: Italian Sales for Advanced Wound Management Products for the Period 2007-2016: $ millions

Exhibit 4-14: Italian Sales Growth for the Main Types of Advanced Wound Management Products for the period 2007-2016: $millions

Exhibit 4-15: UK Sales for Advanced Wound Management Products for the Period 2007-2016

Exhibit 4-16: UK Sales Growth for the Main Types of Advanced Wound Management Products for the Period 2007-2016

Exhibit 5-1: Carrington Laboratories Financial Highlights

Exhibit 5-2: Coloplast Revenue Growth by Business Area

Exhibit 5-3: Derma Sciences, 1st Quarter 2007

Exhibit 5-4: Johnson & Johnson Member Companies

Exhibit 5-5: Ethicon Sales, 2004-2006; $ millions

Exhibit 5-6: Hartmann Historic Sales and Profit Data, Reported in €’000

Exhibit 5-7: 3M Healthcare

Exhibit 5-8: Mölnlycke Health Care AB Revenues

Exhibit 5-9: Smith & Nephew Financials, Q1-Q3, 2007

Exhibit 5-10: Recent Top-Line Financial Data for Mylan

Exhibit 5-11: Advanced Wound Management Products and Suppliers

Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan & Rest of World

Price: $3,950 (print or PDF; add $200 for both). Site/Global also available.